Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...

Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

Trump said in a statement Tuesday night that Ramaswamy and Musk—the wealthiest person in the world, who oversees six ...

On the Readout LOUD podcast, hear what a Harris or Trump presidency would mean for health care policy, and learn about Eli ...

Glassdoor, Payscale, or more specifically BioPharmGuy (to look through a large variety of job offers similar to yours) are ...

Spero Therapeutics Inc. is pulling the plug on a lung disease drug trial and reducing its workforce by 39%. The Cambridge ...

Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.

Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 ...